Bora Pharmaceuticals Co., Ltd. Announces Q1 2026 EPS of NT$0.21
Bora Pharmaceuticals Co., Ltd. has released its financial results for the first quarter of 2026, reporting an earnings per share (EPS) of NT$0.21, operating revenue of NT$4.001 billion, and net profit after tax of NT$0.32 billion. These figures highlight the company's financial performance within the biotechnology and medical industry.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: May 14, 2026 at 08:00 (1775h 0m after Published)
- 🤖 AI Analyzed: May 14, 2026 at 08:16 (15 min after Collected)
Company Code: 6472
Company Name: Bora Pharmaceuticals Co., Ltd.
Industry: Biotechnology and Medical Industry
Fiscal Period: Q1 2026
Basic Earnings Per Share (EPS): NT$0.21
Operating Revenue: NT$4.001 billion
Net Profit After Tax: NT$0.32 billion
Company Name: Bora Pharmaceuticals Co., Ltd.
Industry: Biotechnology and Medical Industry
Fiscal Period: Q1 2026
Basic Earnings Per Share (EPS): NT$0.21
Operating Revenue: NT$4.001 billion
Net Profit After Tax: NT$0.32 billion